Michael Byrnes is Chief Financial Officer of eFFECTOR Therapeutics, Inc.. Currently has a direct ownership of 3,117 shares of EFTR, which is worth approximately $0. The most recent transaction as insider was on May 15, 2024, when has been sold 1,387 shares (Common Stock) at a price of $1.68 per share, resulting in proceeds of $2,330. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.12K
0% 3M change
91.96% 12M change
Total Value Held $0

Michael Byrnes Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 15 2024
BUY
Grant, award, or other acquisition
$2,330 $1.68 p/Share
1,387 Added 30.79%
3,117 Common Stock
Nov 15 2023
BUY
Grant, award, or other acquisition
$2,262 $0.5 p/Share
4,524 Added 9.47%
43,271 Common Stock
May 15 2023
BUY
Grant, award, or other acquisition
$2,236 $0.46 p/Share
4,863 Added 11.15%
38,747 Common Stock
Nov 15 2022
BUY
Grant, award, or other acquisition
$2,185 $0.47 p/Share
4,651 Added 12.07%
33,884 Common Stock
Jun 07 2022
BUY
Open market or private purchase
$33,250 $1.33 p/Share
25,000 Added 46.1%
29,233 Common Stock
May 13 2022
BUY
Grant, award, or other acquisition
$6,476 $1.53 p/Share
4,233 Added 50.0%
4,233 Common Stock

Also insider at

PBAXU
PHOENIX BIOTECH ACQUISITION CORP. Financial Services
MB

Michael Byrnes

Chief Financial Officer
Solana Beach, CA

Track Institutional and Insider Activities on EFTR

Follow eFFECTOR Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EFTR shares.

Notify only if

Insider Trading

Get notified when an E Ffector Therapeutics, Inc. insider buys or sells EFTR shares.

Notify only if

News

Receive news related to eFFECTOR Therapeutics, Inc.

Track Activities on EFTR